Suppr超能文献

哪些有鸡胸肺炎的儿童可以安全地在家中治疗,以及在什么条件下可以安全地这样做?来自中低收入国家的证据的系统评价。

Which children with chest-indrawing pneumonia can be safely treated at home, and under what conditions is it safe to do so? A systematic review of evidence from low- and middle-income countries.

出版信息

J Glob Health. 2022 Aug 31;12:10008. doi: 10.7189/jogh.12.10008.

Abstract

BACKGROUND

WHO pneumonia guidelines recommend that children (aged 2-59 months) with chest indrawing pneumonia and without any "general danger sign" can be treated with oral amoxicillin without hospital admission. This recommendation was based on trial data from limited contexts whose generalisability is unclear. This review aimed to identify which children with chest-indrawing pneumonia in low- and middle-income countries can be safely treated at home, and under what conditions is it safe to do so.

METHODS

We searched MEDLINE, EMBASE, and PubMed for observational and interventional studies of home-based management of children (aged 28 days to four years) with chest-indrawing pneumonia in low- or middle-income countries.

RESULTS

We included 14 studies, including seven randomised trials, from a variety of urban and rural contexts in 11 countries. Two community-based and two hospital-based trials in Pakistan and India found that home treatment of chest-indrawing pneumonia was associated with similar or superior treatment outcomes to hospital admission. Evidence from trials (n = 3) and observational (n = 6) studies in these and other countries confirms the acceptability and feasibility of home management of chest-indrawing pneumonia in low-risk cases, so long as safeguards are in place. Risk assessment includes clinical danger signs, oxygen saturation, and the presence of comorbidities such as undernutrition, anaemia, or HIV. Pulse oximetry is a critical risk-assessment tool that is currently not widely available and can identify severely ill patients with hypoxaemia otherwise possibly missed by clinical assessment alone. Additional safeguards include caregiver understanding and ability to return for review.

CONCLUSIONS

Home treatment of chest-indrawing pneumonia can be safe but should only be recommended for children confirmed to be low-risk and in contexts where appropriate care and safety measures are in place.

摘要

背景

世界卫生组织肺炎指南建议,无任何“一般危险征象”的 2-59 月龄儿童,若患有吸气性肺炎,可在不住院的情况下接受口服阿莫西林治疗。该建议基于特定背景下有限试验数据,其普遍性尚不清楚。本综述旨在确定中低收入国家中哪些有吸气性肺炎的儿童可以安全地在家中治疗,以及在何种情况下可以安全地这样做。

方法

我们检索了 MEDLINE、EMBASE 和 PubMed 中关于中低收入国家儿童(28 天至 4 岁)在家中管理吸气性肺炎的观察性和干预性研究。

结果

我们纳入了来自 11 个国家的 14 项研究,包括 7 项随机试验,来自各种城市和农村背景。来自巴基斯坦和印度的两项基于社区和两项基于医院的试验发现,家庭治疗吸气性肺炎与住院治疗的疗效相似或更优。来自这些国家和其他国家的试验(n=3)和观察性研究(n=6)的证据证实,只要有保障措施,低危病例在家中管理吸气性肺炎是可行的。风险评估包括临床危险征象、氧饱和度以及营养不良、贫血或 HIV 等合并症的存在。脉搏血氧仪是一种关键的风险评估工具,目前尚未广泛普及,它可以识别出可能因临床评估单独遗漏的严重缺氧患者。其他保障措施包括照顾者的理解能力和能够返回进行复查。

结论

家庭治疗吸气性肺炎可能是安全的,但仅应推荐给确诊为低风险的儿童,并在有适当护理和安全措施的情况下进行。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f7e/9428503/839a246abc00/jogh-12-10008-F1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验